MIR6750

Across TCGA pan-cancer cohorts, MIR6750 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR6750’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where MIR6750 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6750 is over-expressed in tumor.

COAD, STAD, and UCEC are the cancer types where MIR6750 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6750 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.595	<.001	5	view →
STAD	All	All	+0.458	.018	3	view →
UCEC	All	IV	+1.589	.006	2	view →
CHOL	Female	All	+0.920	<.001	2	view →
KIRC	Male	II,III,IV	+0.077	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR6750–COAD

Open the COAD breakdown →